Common cinnamon metabolite shows potential for Alzheimer's treatment by reducing amyloid in blood

September 22, 2025

•

1 min read

•

PsyPost

Researchers have discovered that an oral dose of sodium benzoate, a widely used food preservative, lowers Alzheimer's-related amyloid proteins in patients. This finding points toward a potentially safe and convenient treatment option compared to current infusion-based therapies for the disease.

A new study suggests that an oral medication, sodium benzoate, may reduce the levels of disease-related proteins in the blood of patients with mild Alzheimer’s disease. The research also indicates that patients who had higher initial levels of a spec... [6918 chars]

Read Original Article

Source: PsyPost

Visit Source

Share this article

Twitter Facebook

Back to health news